Startup Management - business planning, fundraising management and leadership through early funding stages, including all operations. Pharmaceutical and Biotech Consulting - Product Planning, Strategic Business Planning, Product Development (Formulation development, CMC, Program management), Technology Development and Intellectual Property (SF Bay Area, France)

We are a San Francisco Bay Area-based R&D-stage biopharmaceutical company aiming to discover, develop and commercialize innovative therapeutics for the treatment of rare and aging-related diseases by addressing the underlying causes of disease initiation and progression, such as oxidative, cellular, and environmental stress. Our proprietary platform is supported by an extensive intellectual property portfolio, part of which has been obtained by assignment from the Buck Institute of Novato, California, the nation's first independent research facility focused solely on understanding the connection between aging and chronic disease. ​Our lead compounds are novel and highly selective therapeutics modulating the mTORC1 pathway. In contrast, chronic exposure to current mTOR inhibitors leads to off-target inhibition of mTORC2, resulting in deleterious effects on metabolic health and immune function.

Vice President, Research & Development